What's new

Moderna Starts Dosing Patients In Mid-Stage Coronavirus Vaccine Trial

This whole thing is starting to smell like Theranos. They release PR statements without any supporting data to prop up their stock price. Also this startup hasn't produced anything before.
 
Back
Top Bottom